Undue regulatory control on phenobarbital--an important yet overlooked reason for the epilepsy treatment gap

Epilepsia. 2015 Apr;56(4):659-62. doi: 10.1111/epi.12929.

Authors

Devender Bhalla¹, Hasan Aziz, Donna Bergen, Gretchen L Birbeck, Arturo Carpio, Esper Cavalheiro, Phetvongsinh Chivorakoun, J Helen Cross, Dismand Houinato, Charles R Newton, Peter Odermatt, Sangeeta Ravat, Erich Schmutzhard, Pierre-Marie Preux

Affiliation

¹ Tropical Neuroepidemiology, INSERM UMR 1094, Limoges, France; University Limoges, School of Medicine, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France; University Hospital Center, Limoges, France.

No abstract available

Publication types

Letter

MeSH terms

Anticonvulsants / adverse effects
Anticonvulsants / therapeutic use*
Drug and Narcotic Control / legislation & jurisprudence*
Epilepsy / diagnosis
Epilepsy / drug therapy*
Humans
Phenobarbital / adverse effects
Phenobarbital / therapeutic use*
Treatment Outcome

Substances

Anticonvulsants
Phenobarbital

Grants and funding